U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
TECELEUKIN
H5ZRB188EI
Possibly Marketed Outside US
General
Names
14
Classification
5
Identifiers
10
Subunits
1
Related Substances
1
TECELEUKIN
H5ZRB188EI
Possibly Marketed Outside US
General
Approval Year
Unknown
139,594
Names
14
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
TECELEUKIN
Official Name
English
RO-23-6019
Code
English
INTERLEUKIN-2 TECELEUKIN [MI]
Common Name
English
BG-8301
Code
English
IMUNACE
Brand Name
English
Showing 1 to 5 of 14 entries
Previous
1
2
3
Next
Classification
5
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of metastatic renal cell carcinoma.
FDA ORPHAN DRUG
36289
Designated
ORPHAN DRUG
Designated
In combination with interferon alfa-2a for the treatment of metastatic malignant melanoma.
FDA ORPHAN DRUG
44790
Designated
ORPHAN DRUG
Designated
Treatment of metastatic malignant melanoma.
FDA ORPHAN DRUG
36389
Recombinant Interleukin
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Recombinant Cytokine
[C1283]
Recombinant Interleukin
[C593]
Recombinant Interleukin-2
NCI_THESAURUS
C587
Designated
ORPHAN DRUG
Designated
In combination with interferon alfa-2a for the treatment of metastatic renal cell carcinoma.
FDA ORPHAN DRUG
44490
Showing 1 to 5 of 5 entries
Previous
1
Next
Identifiers
10
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
NCI_THESAURUS
C80836
PRIMARY
FDA UNII
H5ZRB188EI
PRIMARY
EVMPD
SUB10856MIG
PRIMARY
USAN
Y-32
PRIMARY
CAS
94218-75-4
ALTERNATIVE
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Subunits
1
Related Substances
1
SUBSTANCE RECORD
H5ZRB188EI
TECELEUKIN
